ROMOSOZUMAB ENHANCES 3D VERTEBRAL STRUCTURE IN WOMEN WITH LOW BONE DENSITY: MAPPING BONE GAINS AT ONE YEAR COMPARED WITH TERIPARATIDE OR PLACEBO

被引:0
|
作者
Poole, K. E. S. [1 ]
Treece, G. M. [1 ]
Pearson, R. A. [2 ]
Gee, A. H. [1 ]
Bolognese, M. A. [3 ]
Brown, J. P. [4 ,5 ]
Goemaere, S. [6 ]
Grauer, A. [7 ]
Hanley, D. A. [8 ]
Mautalen, C. [9 ]
Recknor, C. [10 ]
Yang, Y. C. [7 ]
Libanati, C. [11 ]
Whitmarsh, T. [1 ]
机构
[1] Univ Cambridge, Cambridge, England
[2] Univ Canterbury, Canterbury, Kent, England
[3] Bethesda Hlth Res Ctr, Bethesda, MD USA
[4] CHU Quebec Res Ctr, Quebec City, PQ, Canada
[5] Laval Univ, Quebec City, PQ, Canada
[6] Ghent Univ Hosp, Ghent, Belgium
[7] Amgen Inc, Thousand Oaks, CA USA
[8] Univ Calgary, Calgary, AB, Canada
[9] Ctr Osteopatias Med, Buenos Aires, DF, Argentina
[10] United Osteoporosis Ctr, Gainesville, FL USA
[11] UCB, Brussels, Belgium
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OC3
引用
收藏
页码:S164 / S164
页数:1
相关论文
共 50 条
  • [31] The Placebo-Controlled Fracture Study in Postmenopausal Women with Osteoporosis: The Foundation Effect of Rebuilding Bone with One Year of Romosozumab Leads to Continued Lower Fracture Risk after Transition to Denosumab
    Cosman, Felicia
    Crittenden, Daria B.
    Ferrari, Serge
    Khan, Aliya
    Lane, Nancy E.
    Lippuner, Kurt
    Matsumoto, Toshio
    Milmont, Cassandra E.
    Libanati, Cesar
    Grauer, Andreas
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [32] The effect of high-dose vitamin D on bone mineral density and bone turnover markers in postmenopausal women with low bone mass—a randomized controlled 1-year trial
    G. Grimnes
    R. Joakimsen
    Y. Figenschau
    P. A. Torjesen
    B. Almås
    R. Jorde
    Osteoporosis International, 2012, 23 : 201 - 211
  • [33] Real-world efficacy of a teriparatide biosimilar (RGB-10) compared with reference teriparatide on bone mineral density, trabecular bone score, and bone parameters assessed using quantitative ultrasound, 3D-SHAPER® and high-resolution peripheral computer tomography in postmenopausal women with osteoporosis and very high fracture risk
    Hadji, Peyman
    Kamali, Luka
    Thomasius, Friederike
    Horas, Konstantin
    Kurth, Andreas
    Bock, Nina
    OSTEOPOROSIS INTERNATIONAL, 2024, 35 (12) : 2107 - 2116
  • [34] Effects of two 1-year calcium and vitamin D3 treatments on bone remodeling markers and femoral bone density in elderly women
    Deroisy, R
    Collette, J
    Chevallier, T
    Breuil, V
    Reginster, JY
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1998, 59 (12): : 850 - 862
  • [35] Effects of physical exercise on bone mass, balance skill and aerobic capacity in women and men with low bone mineral density, after one year of training - a prospective study
    Kronhed, ACG
    Moller, M
    SCANDINAVIAN JOURNAL OF MEDICINE & SCIENCE IN SPORTS, 1998, 8 (05) : 290 - 298
  • [36] Age-related changes of vertical and horizontal lumbar vertebral trabecular 3D bone microstructure is different in women and men
    Thomsen, Jesper Skovhus
    Niklassen, Andreas Steenholt
    Ebbesen, Ebbe Nils
    Bruel, Annemarie
    BONE, 2013, 57 (01) : 47 - 55
  • [37] Longitudinal changes in 3D microarchitecture of paired iliac crest bone biopsies in postmenopausal women with osteoporotic vertebral fracture.
    Zhao, JJ
    Jiang, Y
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S338 - S338
  • [38] Odanacatib in the Treatment of Postmenopausal Women with Low Bone Mineral Density: 3-Year Continued Therapy and Resolution of Effect
    Reid, Ian
    Eisman, John
    Bone, Henry
    Hosking, David
    McClung, Michael
    Rizzoli, Rene
    Resch, Heinrich
    Verbruggen, Nadia
    Hustad, Carolyn
    DaSilva, Carolyn
    Santora, Arthur
    Ince, Avery
    Lombardi, Antonio
    BONE, 2010, 46 : S31 - S32
  • [39] The effect of high-dose vitamin D on bone mineral density and bone turnover markers in postmenopausal women with low bone mass-a randomized controlled 1-year trial
    Grimnes, G.
    Joakimsen, R.
    Figenschau, Y.
    Torjesen, P. A.
    Almas, B.
    Jorde, R.
    OSTEOPOROSIS INTERNATIONAL, 2012, 23 (01) : 201 - 211
  • [40] ODANACATIB TREATMENT OF POSTMENOPAUSAL WOMEN WITH LOW BONE MINERAL DENSITY: 3-YEAR CONTINUED THERAPY AND RESOLUTION OF EFFECT
    Rizzoli, R.
    Eisman, J. A.
    Bone, H.
    Hosking, D.
    McClung, M.
    Reid, I.
    Resch, H.
    Verbruggen, N.
    Santora, A.
    Hustad, C.
    Lombardi, A.
    OSTEOPOROSIS INTERNATIONAL, 2010, 21 : 27 - 27